Remplir is a best in class product for use as a nerve cap to reduce pain for affected patients and manage painful neuromas, thus reducing analgesic reliance and healthcare costs.
Paul mentioned the use of Remplir as a nerve cap represents an organic opportunity over and above the current stated TAM of Remplir for connecting and repairing nerve. In the U.S. alone, there are unfortunately an estimated 185,000 patients each year affected by amputations who would benefit from nerve capping with Remplir.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.25 |
Change
0.040(3.31%) |
Mkt cap ! $304.1M | |||
| Open | High | Low | Value | Volume |
| $1.30 | $1.33 | $1.23 | $1.401M | 1.104M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 4275 | $1.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 4797 | 1 |
View Market Depth
| Last trade - 16.17pm 27/06/2025 (20 minute delay) ? |
| OCC (ASX) Chart |